Assessment of Mitral Stenosis Severity

Primary Echocardiographic Parameters for Severity Assessment

The European Society of Cardiology recommends that mitral valve area (MVA) is the most direct measure of stenosis severity, with severe stenosis defined as MVA < 1.0 cm², moderate stenosis defined as MVA 1.0-1.5 cm², and mild stenosis defined as MVA > 1.5 cm² 1, 2, 3
The American Heart Association suggests that mean transmitral gradient is an important hemodynamic parameter, with severe stenosis defined as > 10 mmHg at rest, moderate stenosis defined as 5-10 mmHg, and mild stenosis defined as < 5 mmHg 3
The European Society of Cardiology states that pulmonary artery systolic pressure (PASP) reflects hemodynamic consequences, with severe stenosis defined as > 50 mmHg at rest, moderate stenosis defined as 30-50 mmHg, and mild stenosis defined as < 30 mmHg 3

The European Society of Cardiology recommends that two-dimensional transthoracic echocardiography (TTE) should be used to measure valve area by planimetry, which is the reference standard for determining severity 4, 5
The American Society of Echocardiography suggests that Doppler echocardiography should be used to calculate mean transmitral gradient using continuous wave Doppler and to estimate valve area using pressure half-time method 5, 6

The European Society of Cardiology indicates that exercise echocardiography is indicated in asymptomatic patients with severe mitral stenosis (MVA < 1 cm²), symptomatic patients with non-severe mitral stenosis (MVA > 1.5 cm²), and patients with discordant symptoms and resting hemodynamics 1, 7
The American College of Cardiology states that criteria for hemodynamically significant mitral stenosis during stress include mean gradient > 15 mmHg during exercise or > 18 mmHg during dobutamine infusion, and PASP > 60 mmHg during exercise 8, 9

The European Society of Cardiology notes that concomitant valve disease, such as associated mitral regurgitation or aortic valve disease, may affect assessment 4, 6
The American Heart Association suggests that body size considerations, such as indexed valve area, may be more appropriate in patients with large body surface area 8, 9

The European Society of Cardiology recommends that transesophageal echocardiography (TOE) is indicated to exclude left atrial thrombus before percutaneous mitral commissurotomy (PMC), when TTE images are suboptimal, and to assess suitability for percutaneous intervention 5, 6
The American Society of Echocardiography states that 3D echocardiography provides more accurate planimetry of valve area, better assessment of commissural fusion and subvalvular apparatus, and comprehensive evaluation of valve morphology from the "surgical view" 10

The American Heart Association and American College of Cardiology guidelines state that mean gradient has not been included in severity criteria due to its variability with heart rate and forward flow 11
In patients with symptomatic mitral stenosis, mean gradients averaged 14-16 mmHg in severe cases requiring intervention, as per the American College of Cardiology 12, 13
The gradient typically ranges from >5-10 mmHg in severe stenosis at normal heart rates, though this varies significantly with heart rate and transvalvular flow, according to the American Heart Association 11

Mitral valve area by planimetry remains the gold standard for determining anatomic severity and should guide management decisions when discordant with gradient, as recommended by the American College of Cardiology 11
The 2014 AHA/ACC guidelines explicitly state that mean gradient should be interpreted in context with mitral valve area and pulmonary pressures, as it depends on multiple hemodynamic variables beyond stenosis severity alone 11

A mean gradient >15 mmHg with exercise indicates significant stenosis warranting intervention consideration, even if resting MVA is >1.5 cm², according to the American Heart Association 12, 14, 13
Exercise gradients >18-20 mmHg suggest poor prognosis and support intervention, as per the American College of Cardiology 15

When evaluating patients with dyspnea, fatigue, or palpitations, obtain resting echocardiography measuring MVA by planimetry, mean gradient by continuous-wave Doppler, and PASP, as recommended by the American College of Cardiology 11
Consider intervention when MVA ≤1.5 cm² with symptoms, regardless of gradient, or when exercise gradient >15 mmHg with symptoms, according to the American Heart Association 12, 14, 11